INGN 241

INGN 241 · Introgen Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INGN 241, covering 2008-04-01 to 2008-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma [Phase 2]